Open AccessIrbesartan protects against type 2 diabetic nephropathy by regulating miR-93/VEGF and its downstream effectors
Author(s) -
Fei Zhao,
Yifei Chen,
Fuhai Yu
Publication year - 2022
Publication title -
tropical journal of pharmaceutical research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.209
H-Index - 36
eISSN - 1596-5996
pISSN - 1596-9827
DOI - 10.4314/tjpr.v21i3.12
Subject(s) - irbesartan , endocrinology , medicine , diabetic nephropathy , saline , nephropathy , diabetes mellitus , chemistry , blood pressure